Bisopair CT 5 Tablet contains Bisoprolol 5mg + Cilnidipine 10mg + Telmisartan 40mg, a triple-action therapy designed for effective management of hypertension and cardiovascular health. Bisoprolol helps regulate heart rate, Cilnidipine relaxes blood vessels for improved circulation, and Telmisartan blocks angiotensin receptors to maintain optimal blood pressure.
This combination is widely trusted by prescribers for its efficacy and patient tolerance, ensuring steady demand. Patients benefit from improved blood pressure control, cardiac protection, and enhanced treatment adherence, making therapy more effective and convenient.
For franchise partners, Bisopair CT 5 Tablet is a high-demand cardiovascular product with excellent market potential. Its proven triple-action mechanism and prescriber confidence make it a profitable addition to any cardiac portfolio, helping expand business reach and strengthen market presence.
With growing incidence of hypertension and cardiovascular disorders, Bisopair CT 5 Tablet provides sustainable sales opportunities and portfolio growth, making it an ideal choice for partners in the cardiac care segment.
Common side effects may include dizziness, headache, fatigue, swelling of ankles, palpitations, or mild gastrointestinal discomfort. Rarely, patients may experience hypotension, bradycardia, or allergic reactions. Any severe or persistent symptoms should be reported promptly to a healthcare professional.
Bisopair CT 5 Tablet is indicated for the management of essential hypertension in adults, especially in patients who need intensified therapy for optimal blood pressure control. It is also suitable for patients with cardiovascular risk factors such as diabetes, kidney disease, or a history of heart disease.
Bisopair CT 5 Tablet should be taken exactly as prescribed by a physician. Regular monitoring of blood pressure, heart rate, and kidney function is recommended. Patients with severe liver or kidney impairment, heart block, or low blood pressure should use this medication cautiously. Do not discontinue therapy abruptly.
Store Bisopair CT 5 Tablet in a cool, dry place below 25°C, protected from sunlight and moisture. Keep out of reach of children and do not use after the expiry date mentioned on the packaging.